Literature DB >> 35536415

Disorders of phosphate homeostasis in children, part 1: primer on mineral ion homeostasis and the roles of phosphate in skeletal biology.

Richard M Shore1,2.   

Abstract

Phosphate has extensive physiological roles including energy metabolism, genetic function, signal transduction and membrane integrity. Regarding the skeleton, not only do phosphate and calcium form the mineral component of the skeleton, but phosphate is also essential in regulating function of skeletal cells. Although our understanding of phosphate homeostasis has lagged behind and remains less than that for calcium, considerable advances have been made since the recognition of fibroblast growth factor-23 (FGF23) as a bone-derived phosphaturic hormone that is a major regulator of phosphate homeostasis. In this two-part review of disorders of phosphate homeostasis in children, part 1 covers the basics of mineral ion homeostasis and the roles of phosphate in skeletal biology. Part 1 includes phosphate-related disorders of mineralization for which overall circulating mineral ion homeostasis remains normal. Part 2 covers hypophosphatemic and hyperphosphatemic disorders, emphasizing, but not limited to, those related to increased and decreased FGF23 signaling, respectively.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Bone; Children; Fibroblast growth factor-23; Generalized arterial calcification of infancy; Hypophosphatasia; Mineralization; Phosphate; Radiography

Year:  2022        PMID: 35536415     DOI: 10.1007/s00247-022-05374-y

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  51 in total

Review 1.  Tumor-induced osteomalacia.

Authors:  M K Drezner
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

Review 2.  Renal and extrarenal effects of fibroblast growth factor 23.

Authors:  Marc Vervloet
Journal:  Nat Rev Nephrol       Date:  2019-02       Impact factor: 28.314

Review 3.  Molecular pathogenesis of hypophosphatemic rickets.

Authors:  Suzanne M Jan de Beur; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2002-06       Impact factor: 5.958

4.  Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice.

Authors:  R A Meyer; M H Meyer; R W Gray
Journal:  J Bone Miner Res       Date:  1989-08       Impact factor: 6.741

Review 5.  Regulation of fibroblast growth factor 23 (FGF23) in health and disease.

Authors:  Ludmilla Bär; Christos Stournaras; Florian Lang; Michael Föller
Journal:  FEBS Lett       Date:  2019-07-05       Impact factor: 4.124

6.  Fibroblast growth factor 23 and phosphate homeostasis.

Authors:  Shanthi Balani; Farzana Perwad
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-09       Impact factor: 2.894

7.  Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.

Authors:  T Shimada; S Mizutani; T Muto; T Yoneya; R Hino; S Takeda; Y Takeuchi; T Fujita; S Fukumoto; T Yamashita
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

Review 8.  Phosphate homeostasis disorders.

Authors:  Marta Christov; Harald Jüppner
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2018-06-18       Impact factor: 4.690

Review 9.  X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment.

Authors:  Yuka Kinoshita; Seiji Fukumoto
Journal:  Endocr Rev       Date:  2018-06-01       Impact factor: 19.871

Review 10.  The journey from vitamin D-resistant rickets to the regulation of renal phosphate transport.

Authors:  Barton S Levine; Charles R Kleeman; Arnold J Felsenfeld
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-01       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.